Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a treatment with Biaxin (clarithromycin) which is an
antibiotic given by mouth for 3 months can delay the growth of your lymphoma or shrink the
lymphoma. We would also like to see how Biaxin (clarithromycin) works on lymphoma and blood
cells.There is some evidence that this medication may change the behavior of lymphocytes, in
addition to its known anti-infection activity.